Bataille AM, Maffeo CL, Renfro JL. Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase. Am J Physiol Renal Physiol 300: F1327-F1338, 2011. First published March 23, 2011 doi:10.1152/ajprenal.00680.2010Urate is a potent antioxidant at high concentrations but it has also been associated with a wide variety of health risks. Plasma urate concentration is determined by ingestion, production, and urinary excretion; however, factors that regulate urate excretion remain uncertain. The objective of this study was to determine whether cellular stress, which has been shown to affect other renal transport properties, modulates urate secretion in the avian renal proximal tubule. Chick kidney proximal tubule epithelial cell primary culture monolayers were used to study the transepithelial transport of radiolabeled urate. This model allowed examination of the processes, such as multidrug resistance protein 4 (Mrp4, Abcc4), which subserve urate secretion in a functional, intact, homologous system. Our results show that the recently implicated urate efflux transporter, breast cancer resistance protein (ABCG2), does not significantly contribute to urate secretion in this system. Exposure to a high concentration of zinc for 6 h induced a cellular stress response and a striking decrease in transepithelial urate secretion. Acute exposure to zinc had no effect on transepithelial urate secretion or isolated membrane vesicle urate transport, suggesting involvement of a cellular stress adaptation. Activation of AMPactivated protein kinase (AMPK), a candidate modulator of ATPdependent urate efflux, by 5=-aminoimidazole-4-carboxamide 1-␤-Dribo-furanoside caused a decrease in urate secretion similar to that seen with zinc-induced cellular stress. This effect was prevented with the AMPK inhibitor compound C. Notably, the decrease in urate secretion seen with zinc-induced cellular stress was also prevented by compound C, implicating AMPK in regulation of renal uric acid excretion.
URATE IS THE MAJOR FORM of nitrogenous waste in birds as well as the end product of purine metabolism in birds, great apes, and humans (24) . In these animals, this organic anion is eliminated primarily by renal proximal tubular secretion, and although ϳ70% of daily urate production is eliminated in the urine, active renal proximal tubule reabsorption in humans and the lack of uricase in both birds and humans allow them to maintain a relatively high plasma urate concentration (ϳ300 M). At this high level, urate has a protective anti-oxidant capacity (3, 4, 6, 27, 61) . However, excessive plasma urate is associated with increased risk for conditions such as gouty arthritis, kidney stones, insulin resistance, cardiovascular disease, and metabolic syndrome (11, 40) . Thus, the control of blood urate requires a balance of production and excretion.
Factors that alter various aspects of production and can result in acute hyperuricemia include high-purine diet (48) , strenuous, exhaustive exercise (25) , fructose ingestion (52) , and tissue injury (5) . Several of these metabolic influences on uric acid production can deplete ATP, increase cellular adenosine, and, in the presence of xanthine oxidase, increase the production and subsequent release of uric acid to plasma. Coincident with the aforementioned, depletion of ATP leads to elevation of cellular AMP levels, potentially activating AMPactivated protein kinase (AMPK) and shifting cells from ATPconsuming to ATP-generating and nutrient uptake processes (26) . One regulatory component of these mechanisms is the activation of cellular stress pathways (12) . The cellular stress response has been shown in other systems to change expression or activity of membrane transporters, an effect that may help restore homeostasis and promote cell survival.
Excretion may alter plasma urate concentration through changes in glomerular filtration rate, tubular reabsorption, and (or) tubular secretion. In both bird and human, ϳ70% of excreted urate enters the urine by tubular secretion. Major candidate urate secretory transporters include multidrug resistance peptide 4 (MRP4; ABCC4) (60) and breast cancer resistance protein (BCRP; ABCG2) (64) . Both are present in human renal proximal tubule apical membrane and capable of urate transport in heterologous systems. In the chick kidney primary proximal tubule epithelial cell primary culture system (cPTC), substrates such as methotrexate and MK-571 inhibit urate secretion, and Mrp4 is localized in the apical membrane (7, 17) . Knocking down Mrp4 expression in this system allowed us to analyze functional effects on the intact epithelium, and we subsequently showed that Mrp4 is a major pathway for apical membrane urate secretion in the chicken proximal tubule (7) . Although urate secretion was greatly reduced by the interfering RNA, it was not eliminated, likely indicating either the incomplete knockdown of Mrp4 expression or participation of other transporters such as Bcrp (64) . BCRP has been implicated recently in human urate secretion (30) ; however, thus far it has been demonstrated as a urate transporter only in heterologous overexpression systems (37, 64) . It remains uncertain whether BCRP plays an important role in renal urate handling in either birds or humans.
Plasma uric acid concentration must be subject to the modulating effects of factors that change the activities of these urate transporters. Since this is an ATP-dependent mechanism, it lends itself to the possibility of regulation by the energysensing enzyme AMPK. Highly conserved among almost all species, AMPK is a heterotrimeric complex consisting of a catalytic ␣-subunit and two regulatory ␤-and ␥-subunits (58) . As an energy regulator for the cell, AMPK senses changes in the AMP:ATP ratio within cells and responds by initiating a conservation mode in which alternate catabolic pathways that generate ATP are turned on and ATP-consuming pathways are turned off (26) . This pathway can be activated by a variety of cellular stressors, such as metabolic poisons (12) , glucose deprivation (13, 46) , ischemia (39) , hypoxia (36) , and oxidative stress (10a), which deplete cellular ATP. Of great relevance to the present study, AMPK has been shown to play a role in regulating a variety of transport processes including inhibition of cystic fibrosis transmembrane conductance regulator (another ABC-type transporter) (32) , inhibition of ATPdependent gastric acid secretion by H ϩ -K ϩ -ATPase in rats (33) , and reduction of sodium gradient-dependent creatine reabsorption by CRT in mouse renal proximal tubule cells (34) . Thus, in response to cellular stress, AMPK may conserve ATP in part by modulating urate transporters such as Mrp4 and thereby slow renal urate secretion.
The present study examined the role of cellular stress and the pharmacological activation of AMPK in regulating avian renal proximal tubule urate secretion. The results indicate that AMPK plays a role in the regulation of urate secretion by the avian kidney during conditions that evoke a cellular stress response.
MATERIALS AND METHODS
Animals. Kidneys were isolated from six to eight Leghorn chicks (domestic Gallus gallus L., 5-7 days of age) for each cell culture preparation and one to two chicks for each brush-border membrane vesicle (BBMV) preparation. This study adheres to the newest Guiding Principles for Research as outlined by the American Physiological Society (2). All investigations involving animals reported in this study were conducted in conformity with these principles, and the animal protocol was approved by the University of Connecticut Institutional Animal Care and Use Committee (protocol no. A05-044).
Solutions and chemicals. Hank's balanced salt solution (HBSS) was purchased from Sigma (St. Louis, MO) as was Krebs-Hensleit buffer, which was supplemented with 4 mM NaHCO 3 (pH 7.4). Final plating medium and medium used to maintain cells consisted of DMEM-HBSS F12 (DME/F12; Mediatech, Herndon, VA) supplemented with insulin/transferrin/selenium premix (5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml selenite; Collaborative Biomedical Products, Sheboygan, WI). This medium was supplemented with 20 M ethanolamine, 300 M L-glutamine, and 10% FBS, complete culture medium (CCM). Percoll was purchased from Amersham Pharmacia Biotech/GE Healthcare (Piscataway, NJ). FBS was purchased from Invitrogen (Carlsbad, CA). Collagenase A was purchased from Roche (Indianapolis, IN).
The saline solution for the Ussing chamber studies contained (in mM) 1.1 CaCl 2, 4.2 KCl, 0.3 MgCl2, 0.4 MgSO4, 120 NaCl, 0.4 NaH2PO4, 0.5 Na2HPO4, 1.0 glycine, 25 NaHCO3 (pH 7.4 with 5% CO2-95% O2, 290 mosmol/kgH2O). In addition, 330 M uric acid and 5.5 mM glucose were added to the solution just before flux determination.
Probenecid, uric acid, phloridzin, Tween 20, Triton X-100, ethanolamine, L-glutamine, D-glucose, HEPES, glycerol, mannitol, tetramethylethylene-diamine, and NaH 2PO4 were purchased from Sigma. 5=-Aminoimidazole-4-carboxamide 1-␤-D-ribo-furanoside (AICAR) was purchased from Biomol International (Plymouth Meeting, PA). Compound C was purchased from Calbiochem (Gibbstown, NJ). THAM, KCl, NaHCO 3, Na2HPO4, MgCl2, glycine, NaCl, ammonium persulfate, SDS, transfer membranes, and membrane filters were purchased from Fisher Scientific (Suwanee, GA).
Preparation of cPTCs. Chicken proximal tubule segments were isolated and dispersed as previously described by Sutterlin and Laverty (55) and modified by Dudas and Renfro (18) . Briefly, kidneys were removed and rinsed thoroughly in HBSS. The tissue was then teased apart to remove blood vessels, ducts, and connective tissue, minced into smaller tissue fragments, and then incubated in an enzyme solution containing collagenase A (0.13 U/ml) and dispase II (0.54 U/ml) at 37°C for 10 min. Nephron segments were further dissociated by trituration and filtration through a stainless steel sieve (380 m), then rinsed three times with HBSS, and resuspended in a 1:1 mixture of Percoll and 2ϫ Krebs-Henseleit buffer. The mixture was centrifuged at 17,500 g and the high-density band containing small proximal tubule segments was removed, rinsed with HBSS, resuspended in culture medium with 10% serum, and plated on native rat tail collagen as previously described (15) . On day 7 in culture, the collagen gels with confluent epithelial monolayers on their surfaces were released from the walls of the culture dishes. By day 14 in culture, these monolayers had contracted the floating collagen rafts from a 25-mm diameter to ϳ12 mm and had achieved full differentiation, at which time they were used for flux experiments, mRNA analysis, and/or protein analysis. Many of the cPTCs used in this study were treated for an extended time with zinc chloride and/or compound C. Those tissues were treated with the respective chemicals for 6 h in culture medium and then put back in normal culture medium for 1.5 h before experimentation. This time course has proven appropriate for the induction of cellular stress in many previous studies and model systems (63) , including primary renal proximal tubule preparations (44) .
Short hairpin RNA interference. Four Bcrp-specific Mission vectorbased shRNA interference constructs in bacterial cells (Sigma) were cloned. The plasmid DNA was extracted from the bacterial cells using the Plasmid Maxi Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions and its concentration was measured by UV spectrophotometry at 260 and 280 nm. The plasmid DNA was then used for transfection of the cPTCs. The four DNA templates are designated as Bcrp sh1185, Bcrp sh2357, Bcrp sh0748, and Bcrp sh1554, where the numbers correspond to the start position in the Bcrp sequence. Of the four DNA templates transfected into the cPTCs, only one template, Bcrp sh1554 (sequence: 5=-GCCAGTCTATGTTAC-CTCTTTCT-3=), successfully knocked down Bcrp expression and was therefore used for subsequent transport studies.
Transfection of cPTCs. The Magnetofection technique was used to transfect the cPTCs with the plasmid DNA. Magnetofection uses a solution of magnetic nanoparticles called the Polymag solution (Boca Scientific, Boca Raton, FL). The magnetic nanoparticles are cationic and designed to bind to DNA. Plasmid DNA was mixed with the Polymag solution and chick culture medium according to the manufacturer's instructions and allowed to bind at room temperature for 30 min. The solution was then added to the lumen-side surface of cPTC confluent monolayers on unreleased collagen, and a strong magnet (Boca Scientific) was placed under the culture dish for 20 min. The magnetic plate draws the magnetic particles, with the DNA bound to them, onto the apical cellular surfaces. By concentrating the DNA on the cells and allowing the cells to take up the DNA by endocytosis, high-efficiency transfection without toxic effects was achieved (7) . RNA, protein, and functional analyses were performed 7 days posttransfection.
RNA isolation, reverse transcription, and real-time PCR. RNA was isolated from cPTCs using the Qiagen RNeasy Kit according to the manufacturer's instructions. RNA concentration and purity were measured by UV spectrophotometry at 260 and 280 nm to ensure that the same amounts of total RNA from the control and Bcrp sh1554-treated tissues were added to the reaction. cDNA was created from the RNA samples using the High Capacity Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Quantification and purity of cDNA were analyzed by UV spectrophotometry at wavelengths 260 and 280 nm. Twenty nanograms of cDNA generated from control and Bcrp sh1554-treated tissues were combined with the Fast SYBR Green Master Mix (Applied Biosystems) and primers (200 nM) designed for Bcrp for use with real-time PCR (forward primer 5=-TTTGTCCATCAGTACAC-CAGCGGA-3=, reverse primer 5=-TACCAGGGCCAGCATGAA-GAAGAA-3=; Integrated DNA Technologies). In addition, control and Bcrp sh1554 cDNA samples were combined with the master mix and primers for ␤-actin (200 nM; forward primer 5=-ATGGATGAG-GAAATCGCTGCC-3=, reverse primer 5=-CTCCCTGATGTCTGG-GTCGTC-3=). The reaction used an initial enzyme activation step at 95°C for 20 s followed immediately by 40 cycles of degradation at 95°C for 3 s and annealing/extension at 60°C for 30 s. Fluorescence was quantified during the annealing/extension step, and product formation was confirmed by melting curve analysis (55-95°C). Data were analyzed during the linear stage of amplification. All samples were run in triplicate. No-amplification-controls where no enzyme was added and no-template-controls where no cDNA samples were added were run to eliminate the possibility of false amplification or amplification of a contaminant. Relative mRNA amounts of target gene, Bcrp, were calculated after normalization to an endogenous reference gene, ␤-actin.
Ussing chamber studies. cPTCs were used to study transepithelial urate transport during days 15-25 of culture by mounting the collagen rafts in Ussing chambers as previously described (23) . The tissues were supported in the chambers by 150-m nylon mesh on the peritubular side and both sides of the tissue were bathed in the saline solution that was kept stirring at 39°C and gassed with humidified 5% CO 2-95% O2 throughout the experiment. Reference electrodes were connected to the bath solutions on both sides of the tissues by 3 mM KCl-2% agar bridges. Electrode asymmetry was corrected at the beginning of each experiment. Transepithelial electrical resistance (TER) was calculated for each tissue from the change in transepithelial electrical potential caused by a 10-A current pulse. Ag-AgCl electrodes were used to pass the current via 3 mM KCl-2% agar bridges and a pair of computer-controlled, high-impedance automatic dual voltage clamps (EVC4000; World Precision Instruments, Sarasota, FL) was used to measure and record electrical properties. At the end of each experiment, the vitality and proximal tubule-like function of the epithelium were monitored by measuring the sodium-dependent glucose current (Iglu). To do this, phloridzin (1 mM), a specific inhibitor of sodium-dependent glucose transport, was added to the bath solution on the luminal side, and the change in transepithelial current was recorded.
Determination of transepithelial UA fluxes. Flux measurement was initiated at t ϭ 0 by the addition of [ 14 C]urate. Steady-state isotopic flux was apparent after 1 h (17). The unidirectional secretory flux, peritubular side to lumen side (P to L), exceeded the unidirectional reabsorptive flux (L to P), revealing net transport of urate in the secretory direction under short-circuited conditions. The addition of 0.01 Ci [
14 C] urate (American Radiolabeled Chemicals, St. Louis, MO) to one side of each tissue at time 0 marked the beginning of the unidirectional fluxes. The flux of radiolabeled urate was measured by taking 50-l samples in duplicate from the bath of the nonlabeled side of the tissue every 30 min for a period of 1.5 h. After each sample was taken, an equal volume of unlabeled physiological saline solution was added back. At the beginning and end of each experiment, 10-l samples were taken from the bath of the labeled side of each tissue to determine the specific activity of the labeled solution.
Net transepithelial flux was determined by the difference between the unidirectional secretory and reabsorptive fluxes (P to L and L to P, respectively). Although chicks do not seem to have any means for active reabsorption of urate, there is urate flux in the reabsorptive direction due to passage through the paracellular pathway (8), which must be considered for calculation of the net transepithelial flux. The net transepithelial flux takes into account the leak flux in both the secretory and the reabsorptive directions under short-circuited conditions (i.e., no transepithelial electrical or chemical gradients); therefore, the difference between the unidirectional fluxes is the active transport, which in this case is secretion.
Isolation of BBMVs and uptake assays. The Mg 2ϩ precipitation method used for the isolation of chick kidney brush-border membranes has been previously described (7) . Briefly, the kidneys were Polytron homogenized in a solution containing 50 mM mannitol, 1 mM tris base and brought to pH 7.4 with HEPES. The Polytron uses sonication to produce membrane fragments that then spontaneously seal to form vesicles. To precipitate the basolateral membrane fragments, 30 mM MgCl2 was added to the mixture and stirred for 20 min on ice. Differential centrifugation in vesicle buffer (usually 200 mM mannitol, 20 mM tris base, pH 7.4 with HEPES) was used to remove the basolateral membrane fragments and other kidney fragments, resulting in a highly enriched BBMV suspension. The enrichment of brush border was increased by 17-to 21-fold compared with homogenate, as confirmed by marker enzyme assays for alkaline phosphatase (brush border), Na ϩ -K ϩ -ATPase (basolateral), and oligomycin-sensitive ATPase (mitochondrial).
The method used for measuring ion transport by the BBMV is a modification of that of Hopfer et al. (29) . Briefly, 10-l samples of BBMV were mixed with 100-l aliquots of incubation buffer (100 mM potassium gluconate, 20 mM tris base, pH 7.4 with HEPES) containing [
14 C]urate and vortexed to begin transport. Transport was stopped after 15 s and 60 min by the addition of an ice-cold solution (100 mM KCl, 5 mM probenecid, pH 7.6 with HEPES). BBMV were then collected on 0.45-m membrane filters (Millipore, 12-mm diameter) and washed with 5 ml of stop solution to eliminate any excess incubation buffer. The filters were placed in a 24-well plate with 400 l Ultima Gold Scintillation Cocktail (Perkin Elmer) in each well and the amount of radiolabeled urate on each filter was measured in a Hidex Chameleon Plate Reader (BioScan, Washington, DC). Filter blanks were done for each incubation buffer and all samples were run in triplicate to eliminate the possibilities of unspecific binding and inconsistent washing, respectively. Na ϩ -K ϩ -ATPase activity assay. To assess the direct effect of AICAR on Na ϩ -K ϩ -ATPase activity, basolateral membranes were isolated by a previously described method (7). This method yields preparations enriched 35-to 55-fold in Na ϩ -K ϩ -ATPase activity and Ͻ1-fold enriched in mitochondrial Mg 2ϩ -ATPase activity. Samples of isolated basolateral membrane from four different preparations were suspended in four different buffers: control buffer (125 mM Tris, 1.8 mM EDTA, 150 mM NaCl, 14 mM KCl, pH 7.7), AICAR buffer (same as control buffer ϩ 0.1 mM AICAR), ouabain buffer (same as control buffer ϩ 1.36 mM ouabain), and ouabain ϩ AICAR buffer (same as ouabain buffer ϩ 0.1 mM AICAR). Ouabain was added to inhibit plasma membrane Na ϩ -K ϩ -ATPase. The samples were all preincubated in a 37°C water bath for 10 min and then 50-l Mg-ATP solution (45 mM magnesium, 30 mM ATP) was added, and the samples were vortexed to initiate the reaction. The reaction was stopped after 15 min by the addition of 1 ml ice-cold color reagent (13% HCl, 8 mM ammonium molybdate, 150 mM ferrous sulfate). Samples were vortexed and removed from the water bath for 20 min before measurement of absorbance at 700 nm. The absorbance of the samples is directly correlated to the amount of inorganic phosphate released.
Protein isolation from cPTCs. cPTCs were removed from CCM and rinsed with a physiological saline solution containing (in mM) 1.1 CaCl 2, 4.2 KCl, 0.3 MgCl2, 0.4 MgSO4, 120 NaCl, 0.4 NaH2PO4, 0.5 Na 2HPO4, 1.0 glycine, 25 NaHCO3 (pH 7.4 with 5% CO2-95% O2, 290 mosmol/kgH 2O) for 30 min to remove serum proteins. cPTCs were then placed in a 0.01% KOH solution containing a mixture of protease inhibitors and vortexed vigorously to remove the proximal tubule cells from the collagen rafts. The supernatant was then transferred to new microcentrifuge tubes and frozen at Ϫ20°C. Once frozen, the samples were lyophilized, and the dry samples were resuspended in a small volume of distilled water (50 l) containing protease inhibitors. A colormetric assay based on the Bradford dyebinding method (Bio-Rad, Hercules, CA) was performed according to the manufacturer's instructions to determine the protein concentration of each sample.
SDS-PAGE and immunoblotting.
Isolated protein samples were combined with an equal volume of 2ϫ Kaman buffer (2.3% SDS, 5% ␤-mercaptoethanol, 10% glycerol, 0.5% bromophenol blue, 62.5 mM Tris·HCl, pH 6.8) and used for SDS-PAGE (7 or 12% resolving gel, 4% stacking gel). The gel products were transferred to a polyvinylidene fluoride (PVDF) microporous membrane (Millipore). Nonspecific binding was prevented in BCRP, heat shock protein 70 (Hsp70), Mrp4, and ␤-actin blots by blocking the membrane with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2HPO4, 1.5 mM KH2PO4, pH 7.3 with HCl) containing 3% nonfat dry milk and 0.05% polyoxyethylenesorbitan monolaurate (Tween 20) for 2 h at room temperature.
No blocking was performed on the AMPK-phospho-Thr172 membranes. Bcrp was detected using a commercially available rat antihuman BCRP antibody (BXP-53, Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:2,000. Hsp70 was detected using a commercially available affinity-purified polyclonal rabbit anti-rat Hsp70 antibody diluted 1:1,000 (U.S. Biological, Swampscott, MA). Mrp4 was detected using a custom polyclonal rabbit anti-chicken Mrp4 antibody diluted 1:1,000 (7). Phosphorylated AMPK was detected using a commercially available rabbit polyclonal AMPK alpha 1 (phospho T172; Abcam, Cambridge, MA) antibody diluted 1:500. AMPKphospho T172 could only be detected if blocking was not performed before blotting with the primary antibody. ␤-Actin protein was detected using a commercially available affinity-purifed polyclonal rabbit anti-chicken ␤-actin antibody diluted 1:10,000 (Sigma). PDVF membranes were incubated in the PBS/dry milk/Tween 20 solution containing the primary antibodies for 1 h at room temperature for BCRP, Hsp70, Mrp4, and ␤-actin antibodies and overnight for the AMPK-p-T172 antibody. The membrane was washed 3 ϫ 10 min in PBS/dry milk/Tween 20 solution. The PVDF membranes were then incubated with the secondary antibody, either goat anti-rabbit IgG peroxidase conjugate (Sigma) or goat anti-rat IgG peroxidase conjugate (Sigma) diluted 1:2,000 in PBS/dry milk/Tween 20 solution, for 1 h at room temperature. The membranes were washed 3 ϫ 10 min in PBS/dry milk/Tween 20 and then washed two times rapidly with PBS.
Detection and quantification. Signals were detected by ECL Western blotting reagents (Pierce) according to the manufacturer's instructions and developed on medical X-ray film (Fujifilm) for analysis. Film exposure time varied depending on the strength of the signal.
Statistics. Results shown are expressed as means Ϯ SE. Experimental means were evaluated using paired t-tests or ANOVA with Tukey Kramer significance test. Significant differences were assumed if P Ͻ 0.05.
RESULTS
Bcrp does not significantly contribute to urate secretion in cPTCs. Transfection of cPTCs with four different Bcrp shRNAi constructs revealed that one of the constructs, Bcrp sh1554, was effective in generating a stable Bcrp knockdown. Quantitative real-time PCR results show that only the cPTCs transfected with Bcrp sh1554 had lower (ϳ90%) Bcrp mRNA than the control cPTCs (Fig. 1A) . The representative immunoblot in Fig. 1B shows dense bands for Bcrp ϳ76 kDa in control, Bcrp sh1185, Bcrp sh2357, and Bcrp sh0748 samples, but it shows no band in the Bcrp sh1554 sample. ␤-Actin bands at ϳ42 kDa confirmed equal loading of protein between samples. The normalized summary pixel density analysis from three different culture preparations shown in Fig. 1C confirmed that transfection with Bcrp sh1554 causes ϳ75% reduction in Bcrp protein expression compared with controls. Summary data (n ϭ 9) of unidirectional and net active transepithelial urate fluxes by control and Bcrp sh1554 cPTCs are presented in Fig. 1D . The results show that knocking down Bcrp had no significant effect on net active transepithelial urate transport (Fig. 1D) , TER (Fig. 1E) , or I glu (Fig. 1F) . This lab previously showed that similar knock down of Mrp4 in the cPTCs resulted in 80% decrease in active urate secretion (7) .
Effect of 6-h exposure to zinc on cellular stress response. Treatment of cPTCs in culture for 6 h with 250 M zinc chloride followed by a 1.5-h recovery time in normal culture medium elicited a cellular stress response characterized by the induction of Hsp70 expression but revealed no change in Mrp4 expression. The Hsp70 representative immunoblot in Fig. 2 shows a faint band for Hsp70 at ϳ70 kDa in control cPTCs and a more dense band at this location in zinc-treated cPTCs. The Mrp4 representative immunoblot in Fig. 2 shows equally dense bands for Mrp4 at ϳ150 kDa in control and zinc-treated cPTCs. ␤-Actin bands at ϳ42 kDa allowed normalization of Hsp70 and Mrp4 protein between samples. The normalized summary pixel density analysis from four paired cPTC preparations shown in Fig. 2 indicated a significant 2 .5-fold increase in Hsp70 expression in cPTCs treated with zinc. Figure 3A is summary data of unidirectional and net active transepithelial urate fluxes in control cPTCs and those treated with the long (6 h) exposure to zinc chloride. Zinc-induced cellular stress completely inhibited active transepithelial urate secretion in cPTCs compared with paired controls. It is unlikely this was due to a generalized metabolic perturbation because, in contrast to urate transport, the reductions in average TER (Fig. 3B ) and I glu (Fig. 3C ) of the zinc-treated cPTCs were relatively minor compared with the effect on urate transport.
Effect of zinc-induced cellular stress on active transepithelial urate secretion.
Acute exposure to zinc has no direct effect on urate transport. Figure 4 shows summary data comparing active transepithelial urate secretion, TER, and I glu of control and cPTCs treated acutely (during flux measurements only) with 250 M ZnCl 2 . This brief exposure to a high concentration of zinc caused no change in transepithelial urate secretion compared with the paired control (Fig. 4A) . There was no significant effect on TER of acute exposure to zinc (Fig. 4B) ; however, the exposure slightly lowered I glu compared with controls (Fig. 4C) . Fig. 2 . Immunoblot analysis of cPTC heat shock protein 70 (Hsp70) and multidrug resistance protein 4 (Mrp4) from untreated controls and paired, identical cPTCs treated for 6 h with 250 M ZnCl2 followed by a 1.5-h recovery in zinc (Zn)-free medium. Rabbit anti-␤-actin antibody (ϳ42 kDa), as described in MATERIALS AND METHODS, was used to normalize loading. All blots were stained with the same goat anti-rabbit peroxidase-conjugated secondary antibody. Hsp70/␤-actin pixel density ratio was the same for each lane. The Hsp70 blot shows a single sample run in duplicate indicating that Hsp70 protein expression increased in the Zn-treated cPTC samples compared with paired controls (C). The Mrp4 blot shows a single C and a single Zn-treated sample and indicates that long exposure to Zn does not change Mrp4 protein expression. Normalized summary data from 4 different culture preparations show that the increase in Hsp70 protein expression caused by Zn was significant (*P Ͻ 0.05).
It is possible that the epithelium might prevent significant intracellular zinc accumulation during acute exposure. However, there was also no effect of zinc from the cytosolic side on urate uptake by chicken kidney BBMV. Table 1 (31, 42) . Based on the data shown in Table  1 , it is clear that urate is driven into the vesicles when a large electrical gradient is imposed (15-s uptake with electrical gradient, 768 Ϯ 49 pmol/mg protein; 15-s uptake without electrical gradient, 130 Ϯ 15 pmol/mg protein) and that zinc had no effect on that process (15-s uptake without zinc, 768 Ϯ 49 pmol/mg protein; 15-s uptake with zinc, 768 Ϯ 122 pmol/mg protein) from either membrane face. The absence of an acute, direct effect of zinc on active transepithelial urate secretion and a nearly complete inhibition following prolonged exposure (and induction of a cellular stress response) implicated other metabolic processes in transport.
AMPK is activated by AICAR and 6-h exposure to zinc. Figure 5 shows that treatment of cPTCs with either 0.1 mM AICAR for 90 min or 250 M zinc chloride for 6 h activated AMPK, as shown by increases in the levels of phosphorylated AMPK. The representative AMPK-phospho-Thr172 immunoblot in Fig. 5A revealed bands for phosphorylated AMPK in all samples, indicating that there is basal AMPK activation in these cells. More importantly, protein isolated from cPTCs treated with AICAR or prolonged zinc (ZnCl 2 ) exhibited higher levels of phosphorylated AMPK, as illustrated by more A: unidirectional, secretory (P to L), reabsorptive (L to P), and net transepithelial transport of urate by control cPTCs and those exposed to 250 M Zn chloride in culture medium for 6 h followed by a 1.5-h recovery period in normal culture medium before flux measurements. B: TERs of paired control and Zn-treated cPTCs. C: Iglu of paired control and Zn-treated cPTCs. Values are means Ϯ SE. *Significantly different from paired control within that measurement group at P Ͻ 0.05. dense bands at ϳ63 kDa, compared with paired controls. ␤-Actin bands at ϳ42 kDa allowed normalization of AMPKphospho-Thr172 between samples. The normalized summary pixel density analysis from different cPTC preparations, shown in Fig. 5B (n ϭ 3) and in Fig. 5C (n ϭ 7) , indicates a significant increase in AMPK-phospho-Thr172 in AICAR (1.8-fold) and ZnCl 2 (1.5-fold) treated cPTCs.
Effect of AMPK activation and inhibition on transepithelial urate secretion. Figure 6 shows summary data comparing active transepithelial secretion of urate, TER, and I glu of control and cPTCs treated with AICAR (AMPK activator), compound C (AMPK inhibitor), or the combination of AICAR and compound C. These substances were placed in both hemichambers at t ϭ 0, and fluxes were determined at 90 min. These data show that the activation of AMPK with 0.1 mM AICAR caused a significant reduction in transepithelial urate secretion and that this decrease was mostly prevented and maintained at control levels by compound C (20 M; Fig. 6A ). AICAR treatment caused a significant change in TER compared with the controls (Fig. 6B) and caused considerable variation, although no significant difference, in I glu (Fig. 6C) .
It was recently shown that the pharmacological activation of AMPK with two compounds, phenformin and AICAR, directly inhibits ouabain-sensitive Na ϩ -K ϩ -ATPase activity in H441 lung cells (65), i.e., intervening AMPK activation is not necessary. If this were also the case in the kidney, the decrease in urate secretion that is seen here could be attributed simply to the decrease in the sodium gradient across the basolateral membrane. Na ϩ -K ϩ -ATPase activity of isolated basolateral membrane samples from chicken kidney was assayed in the presence and absence of 0.1 mM AICAR. The results of the enzymatic assay show no difference (P ϭ 0.3) in Na ϩ -K ϩ -ATPase activity, measured by phosphate release, when AICAR was added to the enzymatic assay (control 83.97 Ϯ 4.01 mol phosphate Immunoblot analysis of cPTC AMPK-phospho-Thr172 from untreated controls and cPTCs treated with 5=-aminoimidazole-4-carboxamide 1-␤-D-ribo-furanoside (AICAR), compound C, ZnCl2, and various combinations. All AICAR treatments were for 1.5 h at 0.1 mM in culture medium. Compound C treatments alone and with AICAR were for 1.5 h at 20 M in culture medium. Zn chloride treatments were for 6 h at 250 M in culture medium followed by a 1.5-h recovery in Zn-free medium. Compound C treatment with ZnCl2 was also done for 6 h followed by a 1.5-h incubation in treatmentfree medium. Rabbit anti-␤-actin antibody (ϳ42 kDa), as described in MATERIALS AND METHODS, was used to normalize loading. All blots were stained with the same goat anti-rabbit peroxidase-conjugated secondary antibody. A: representative blot shows all 6 treatments from 1 cPTC preparation. B and C: normalized summary data from 3-7 different culture preparations show that the increases in AMPK-phospho-Thr172 protein expression in AICAR-and ZnCl2-treated cPTCs were significantly different from that of control cPTCs. The addition of compound C to ZnCl2-treated cPTCs completely prevented the increase AMPK-phospho-Thr172 (*P Ͻ 0.05). Figure 7 shows summary data comparing active transepithelial secretion of urate, TER, and I glu of control cPTCs with that of those treated with 6-h exposure to ZnCl 2 , compound C (AMP kinase inhibitor), or 6-h exposure to ZnCl 2 together with 20 M compound C. The 6-h treatments were done in culture medium followed by a 1.5-h recovery period in culture medium with neither zinc nor the inhibitor before flux measurements were started (t ϭ 0). The reduction in transepithelial urate secretion by zinc-induced cellular stress was completely prevented by compound C (20 M; Fig. 7A ). None of the treatments caused a change in TER (Fig. 7B) or I glu (Fig. 7C ) compared with controls.
DISCUSSION
The in vitro evidence provided in the present study indicates that cellular stress and activation of AMPK in renal proximal tubule epithelium can alter active uric acid secretion. Prolonged exposure to a high concentration of zinc elicited the expected cellular stress response in cPTCs, i.e., the induction of Hsp70; however, the heavy metal markedly decreased active transepithelial urate secretion. The effect could not be attributed to a direct inhibition by zinc of uric acid transport pathways since there was neither an acute effect of zinc on the intact epithelium nor an effect from the cytosolic side of isolated BBMV. This suggested a metabolic effect of zincinduced cellular stress and prompted our examination of the role of the metabolic sensor, AMPK. Activation of AMPK in cPTCs by AICAR caused a similar decrease in transepithelial urate secretion as that seen with zinc-induced cellular stress and was prevented by the addition of the AMPK inhibitor compound C. Most notably, the decrease in urate secretion observed during zinc-induced cellular stress was also prevented by compound C, implicating AMPK in a pathway regulating active renal tubular urate secretion following cellular stress in this renal system. Although this evidence suggests that AMPK plays a critical role in the zinc-induced regulation of urate secretion, the exact mechanism of this phenomenon is largely unknown and could be the result of an indirect action involving several other factors.
Elevated zinc is a well-known and effective stimulator of the cellular stress response in chicken embryonic cells, manifested by the induction of hsps (63) , a result of lowlevel protein denaturation (28) . In addition, exposure to elevated zinc for 6 h followed by a 1.5-h zinc-free recovery period was previously shown by our lab to be an appropriate time course for initiating a cellular stress response in primary cultured renal epithelial cells (44) . The high concentration of zinc that was used in the present study was necessary to significantly induce Hsp70, and the resulting damage likely explains the slight changes in TER and I glu seen in the zinc-treated cPTCs (see Figs. 3 and 4) . These reductions, although significant, were not sufficient to account for the dramatic decrease in transepithelial transport of urate caused by cellular stress. Active net transepithelial urate transport was unchanged in cPTCs exposed acutely to zinc even though the I glu was slightly reduced, indicating that this low-level damage, and possible generalized metabolic perturbation, was not a direct influence on urate transport.
The cellular stress response in renal proximal tubule can increase transepithelial solute transport (9, 44, 53, 54) , and, based on the latter studies of inorganic sulfate and organic cation transport in flounder renal proximal tubule epithelium and glucose transport in OK cells (opossum kidney cell line), we had anticipated there would be a stimulation of urate transport associated with the cellular stress response in the avian cPTCs. This hypothesis was supported by work in killifish isolated, intact renal proximal tubules, where Mrp-like transport increases in response to continuous exposure to the nephrotoxic heavy metal salt CdCl 2 (56) as well as sublethal arsenite exposures (38) and extended exposure to gentamicin (41) . In addition, studies in hepatocytes show that oxidative stress caused by exposure to acetaminophen results in an increase in expression of Mrp4 (1) . Contrary to these studies, we found no change in Mrp4 expression upon zinc-induced cellular stress and a surprising decrease in urate secretion. Based on our observation that cellular stress reduced urate secretion in an indirect manner and unrelated to expression changes in Mrp4, we examined the possibility that the metabolic state during cellular stress might account for the reduction. Several studies show that ATP is depleted during many forms of cellular stress, including anoxia (21), heat shock (20), arsenite toxicity (10), and most relevant to this study, heavy metal exposure (35) . There is also direct evidence in Hep-2 cells that zinc induces ATP depletion and oxidative stress at a similar concentration and time course (300 M for 8 h) (45) as were used in our study (250 M for 6 h). Zinc-induced depletion of ATP has been previously attributed to a reduction in ATP production by inhibition of glycolysis, the Krebs cycle, and oxidative phosphorylation in a variety of cell models (16) . AMPK is a major regulator of the metabolic state of the cell and senses ATP depletion; thus, its role in regulating the apical membrane, ATP-dependent urate secretion may serve energy conservation. However, plasma urate entering on the basolateral membrane organic anion transporters (Oat1/3) may accumulate if active expulsion to the lumen declines and would likely result in a higher level of intracellular urate, which, as a potent anti-oxidant, could be beneficial for cell survival during stress.
Although our results clearly demonstrate that AMPK plays a role in urate secretion, slight changes in TER and I glu were seen with the activation of AMPK by the addition of AICAR. Activation of AMPK could potentially inhibit several other ATP-dependent processes that might change the overall vitality and function of the epithelium. The average TER of the epithelia exposed to AICAR was significantly reduced compared with controls (Fig. 6B) ; however, the reduction in net active transepithelial flux of urate (Fig. 6A) is not likely to be an effect of that reduction because the TER of AICAR-, compound C-, or AICAR plus compound C-treated cPTCs are all the same (Fig. 6B) . Among the aforementioned, only AICAR treatment significantly reduced net transepithelial urate transport compared with controls (Fig. 6A) , indicating that the change in net transport is not directly correlated with the reduction in TER. AICAR treatment was also associated with considerable variation in I glu compared with controls (Fig. 6C) ; however, these current variations were not significant and do not correspond to the changes that occurred in transepithelial urate transport.
Tubular secretion of urate is dependent on active processes at both the basolateral and brush-border (apical) membranes. Proposed secretion models in both humans and birds suggest that urate is transported across the basolateral membrane into the proximal tubule cell by Oat1 and Oat3 in exchange for ␣-ketoglutarate (␣-KG) (22, 43, 62) . This tertiary active transport process relies on the generation of a sodium gradient by Na ϩ -K ϩ -ATPase and the recycling of ␣-KG by the Na ϩ / dicarboxylate cotransporter (14) . Notably, the changes reported here in transepithelial urate secretion caused by AICAR could not be attributed to direct inhibition of the basolateral membrane Na ϩ -K ϩ -ATPase that is necessary for urate influx. Efflux of urate across the proximal tubule apical membrane in humans is less certain. Arguably the most likely candidate, MRP4, has been localized to the apical membrane in human proximal tubule cells (59) and has been shown to transport urate when overexpressed in insect sf9 membrane vesicles and HEK293 cells (60) . Direct evidence for Mrp4-mediated urate secretion in the avian renal proximal tubule was demonstrated by an 80% reduction in transepithelial urate secretion upon knockdown of Mrp4 expression (7) . Although no direct evidence exists for MRP4 as the dominant pathway for apical membrane urate efflux in humans, the direct evidence in the chicken combined with the fact that the chicken and human have remarkably similar mechanisms for basolateral entry of urate provides a strong argument for drawing tentative parallels between their apical membrane exit mechanisms. MRP4 is the only known exit pathway for urate secretion in humans (19) ; however, more recent studies indirectly implicated BCRP (ABCG2) in urate secretion in human proximal tubule. BCRP was shown to transport urate in heterologous systems (37, 64) and is present in the apical membrane of the human renal proximal tubule (30) . However, knocking down Bcrp gene expression in chicken renal proximal tubule epithelium has no effect on urate secretion (Fig. 1) , supporting Mrp4 as the major pathway for urate secretion in this system. Understanding how this pathway might be regulated by AMPK will provide a better understanding of how urate homeostasis is achieved. Currently, there is no evidence for AMPK phosphorylation of Mrp4 in any system; however, several cytosolic phosphorylation sites have been identified on human Mrp4, and thus regulation of this transporter by phosphorylation remains a viable hypothesis. In addition, the chicken Mrp4 amino acid sequence reveals a motif (RxxSxxxV) at serine 658 similar to that found in other previously identified AMPK phosphorylation sites (RxxSxxxL) on as many as 10 other AMPK-regulated proteins (phosphosite.org; phospho.elm.eu.org/; motif-x.med. harvard.edu/). Based on this computational analysis, future examination of whether AMPK directly phosphorylates chicken Mrp4 is warranted. Another possibility is that AMPK regulates Mrp4 indirectly, such as in the case of AMPK and the creatine transporter CRT (34) . It has recently been shown that activation of AMPK inhibits CRT activity in oocytes but that exposure to CRT to purified AMPK holoenzyme does not result in phosphorylation of CRT (34) . This result is indicative of an indirect mechanism of regulation. Determining the precise relationship between AMPK and Mrp4 remains a future goal and will be an important contribution to understanding the processes that modulate urate secretion.
In summary, urate secretion by the intact avian proximal tubule epithelium is regulated by a cellular stress-induced pathway that involves the metabolic regulator AMPK. Further studies regarding the connection between AMPK and Mrp4 are necessary to determine whether this effect is caused by a direct interaction between these two proteins.
Perspectives
Although associated with a variety of health risks, maintaining high plasma urate levels is thought to also be beneficial as it is a well-known physiological scavenger of peroxynitritederived radicals. Although urate reacts slowly with peroxynitrite itself, it reacts efficiently with the free radical intermediates (·CO 3 Ϫ· and·NO 2 ) generated by the fast reaction between peroxynitrites and CO 2 and serves as a first line of defense against these radicals in biological systems (51) . This impact has been shown to be especially important in neurodegenerative diseases such as multiple sclerosis (49, 50), Parkinson's disease, and Alzheimer's disease (57) , where high plasma urate levels may be protective. Interestingly, AMPK is activated during oxidative stress and, specifically, in response to high levels of peroxynitrites (66) . The findings reported here predict that activation of AMPK during cellular stress conditions would result in a decrease in renal urate secretion and presumably an increase in plasma urate levels which, in turn, would protect against the inevitable peroxynitrite free radical intermediates.
